KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹32 Cr | ₹37 Cr | ₹33 Cr | ₹33 Cr | ₹33 Cr |
What is the latest Total Non-Current Liabilities ratio of KOPRAN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹32 Cr |
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹33 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹33 Cr |
How is Total Non-Current Liabilities of KOPRAN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹32 Cr | -13.07 | |
| Mar2025 | ₹37 Cr | 9.64 | |
| Mar2024 | ₹33 Cr | -0.03 | |
| Mar2023 | ₹33 Cr | 1.05 | |
| Mar2022 | ₹33 Cr | - | |
Compare Total Non-Current Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹841.4 Cr | -11.1% | -15.8% | 9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -11.1% |
-15.8% |
9.4% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses